| Adherence to the ‘atrial fibrillation better care’pathway in patients with atrial fibrillation: impact on clinical outcomes—a systematic review and meta-analysis of 285,000 … GF Romiti, D Pastori, JM Rivera-Caravaca, WY Ding, YX Gue, ... Thrombosis and haemostasis 122 (03), 406-414, 2022 | 380 | 2022 |
| Polypill strategy in secondary cardiovascular prevention JM Castellano, SJ Pocock, DL Bhatt, AJ Quesada, R Owen, ... New England Journal of Medicine 387 (11), 967-977, 2022 | 258 | 2022 |
| COVID-19 in Italy: ageism and decision making in a pandemic M Cesari, M Proietti Journal of the American Medical Directors Association 21 (5), 576, 2020 | 246 | 2020 |
| Adherence to oral anticoagulant therapy in patients with atrial fibrillation V Raparelli, M Proietti, R Cangemi, GYH Lip, DA Lane, S Basili Thrombosis and haemostasis 117 (02), 209-218, 2017 | 234 | 2017 |
| Apixaban for stroke prevention in subclinical atrial fibrillation JS Healey, RD Lopes, CB Granger, M Alings, L Rivard, WF McIntyre, ... New England Journal of Medicine 390 (2), 107-117, 2024 | 223 | 2024 |
| Improved population-based clinical outcomes of patients with atrial fibrillation by compliance with the simple ABC (Atrial Fibrillation Better Care) pathway for integrated care … M Yoon, PS Yang, E Jang, HT Yu, TH Kim, JS Uhm, JY Kim, JH Sung, ... Thrombosis and haemostasis 119 (10), 1695-1703, 2019 | 222 | 2019 |
| Asymptomatic versus symptomatic atrial fibrillation: a systematic review of age/gender differences and cardiovascular outcomes Q Xiong, M Proietti, K Senoo, GYH Lip International journal of cardiology 191, 172-177, 2015 | 209 | 2015 |
| Improved outcomes by integrated care of anticoagulated patients with atrial fibrillation using the simple ABC (Atrial Fibrillation Better Care) pathway M Proietti, GF Romiti, B Olshansky, DA Lane, GYH Lip The American journal of medicine 131 (11), 1359-1366. e6, 2018 | 207 | 2018 |
| Frailty: what is it? M Proietti, M Cesari Frailty and Cardiovascular Diseases: Research into an Elderly Population, 1-7, 2020 | 184 | 2020 |
| Atrial fibrillation and thromboembolism in patients with chronic kidney disease YC Lau, M Proietti, E Guiducci, AD Blann, GYH Lip Journal of the American College of Cardiology 68 (13), 1452-1464, 2016 | 162 | 2016 |
| Real-world use of apixaban for stroke prevention in atrial fibrillation: a systematic review and meta-analysis M Proietti, I Romanazzi, GF Romiti, A Farcomeni, GYH Lip Stroke 49 (1), 98-106, 2018 | 161 | 2018 |
| Evaluation of the HAS-BLED, ATRIA, and ORBIT bleeding risk scores in patients with atrial fibrillation taking warfarin K Senoo, M Proietti, DA Lane, GYH Lip The American journal of medicine 129 (6), 600-607, 2016 | 160 | 2016 |
| Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation … G Boriani, M Proietti, C Laroche, L Fauchier, F Marin, M Nabauer, ... Ep Europace 20 (5), 747-757, 2018 | 158 | 2018 |
| Is There an Obesity Paradox for Outcomes in Atrial Fibrillation? A Systematic Review and Meta-Analysis of Non–Vitamin K Antagonist Oral Anticoagulant Trials M Proietti, E Guiducci, P Cheli, GYH Lip Stroke 48 (4), 857-866, 2017 | 145 | 2017 |
| Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: a multicountry patient-level meta-analysis of 141,220 … N Lowres, J Olivier, TF Chao, SA Chen, Y Chen, A Diederichsen, ... PLoS medicine 16 (9), e1002903, 2019 | 123 | 2019 |
| Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trial M Proietti, V Raparelli, B Olshansky, GYH Lip Clinical Research in Cardiology 105, 412-420, 2016 | 121 | 2016 |
| Comprehensive management with the ABC (Atrial Fibrillation Better Care) pathway in clinically complex patients with atrial fibrillation: a post hoc ancillary analysis from the … M Proietti, GF Romiti, B Olshansky, DA Lane, GYH Lip Journal of the American Heart Association 9 (10), e014932, 2020 | 119 | 2020 |
| Revisiting the effects of omitting aspirin in combined antithrombotic therapies for atrial fibrillation and acute coronary syndromes or percutaneous coronary interventions … TS Potpara, N Mujovic, M Proietti, N Dagres, G Hindricks, JP Collet, ... EP Europace 22 (1), 33-46, 2020 | 108 | 2020 |
| Relation of outcomes to ABC (Atrial Fibrillation Better Care) pathway adherent care in European patients with atrial fibrillation: an analysis from the ESC-EHRA EORP Atrial … M Proietti, GYH Lip, C Laroche, L Fauchier, F Marin, M Nabauer, ... EP Europace 23 (2), 174-183, 2021 | 102 | 2021 |
| ‘Real-world’atrial fibrillation management in Europe: observations from the 2-year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry … M Proietti, C Laroche, G Opolski, AP Maggioni, G Boriani, GYH Lip, ... Europace 19 (5), 722-733, 2017 | 102 | 2017 |
